TEAS RF New Application

SYNTHEA

The MITRE Corporation

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2018)

Trademark/Service Mark Application, Principal Register

Serial Number: 87686582
Filing Date: 11/15/2017

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 87686582
MARK INFORMATION
*MARK SYNTHEA
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT SYNTHEA
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK The MITRE Corporation
*STREET 7515 Colshire Drive
*CITY McLean
*STATE
(Required for U.S. applicants)
Virginia
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
22102-7508
PHONE 202-371-2600
FAX 202-371-2540
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS  
*IDENTIFICATION An approach, method, and software program for generating synthetic patients and synthetic electronic patient healthcare records for use by the healthcare industry, for research and innovation purposes, and for educational purposes; software that simulates the lifespan of synthetic patients for use by the healthcare industry, for research and innovation purposes, and for educational purposes; software for modeling primary healthcare encounters, chronic conditions, and treatment protocols within a synthetic patient population for use by the healthcare industry, for research and innovation purposes, and for educational purposes; software for generating synthetic patients; software for simulating patients; software for simulating patients with models of disease progression and corresponding standards of care to produce risk-free, realistic, synthetic, healthcare records at scale; a synthetic patient population simulator used to generate synthetic patients and synthetic patient data; providing synthetic patient data and associated healthcare records; software for generating synthetic patient data; software for generating synthetic patient healthcare records
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Tracy-Gene G. Durkin
ATTORNEY DOCKET NUMBER 2272.2290000
FIRM NAME Sterne, Kessler, Goldstein & Fox P.L.L.C.
STREET 1100 New York Avenue, NW
CITY Washington
STATE District of Columbia
COUNTRY United States
ZIP/POSTAL CODE 20005
PHONE 202-371-2600
FAX 202-371-2540
EMAIL ADDRESS tm@skgf.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY Robert G. Sterne, Jorge A. Goldstein, David K. S. Cornwell, Robert W. Esmond, Michele A. Cimbala, Michael B. Ray, Robert E. Sokohl, Eric K. Steffe, Michael Q. Lee, John M. Covert, Robert C. Millonig, Donald J. Featherstone, Timothy J. Shea, Jr., Jeffrey T. Helvey, Eldora L. Ellison, Donald R. Banowit, Peter A. Jackman, Michael D. Specht, Gaby L. Longsworth, Lori A. Gordon, Jon E. Wright, Tracy-Gene G. Durkin, Monica Riva Talley, Michelle K. Holoubek, Paul A. Calvo, Marsha A. Rose, Mark W. Rygiel, Byron L. Pickard, Daniel E. Yonan, Jason D. Eisenberg, Kenley K. Hoover, Deborah Sterling, Salvador M. Bezos, Carla Ji-Eun Kim, Paul A. Ainsworth, Jeremiah B. Frueauf, Richard D. Coller, III, Dennies Varughese, Jonathan Tuminaro, Nirav N. Desai, Uma N. Everett, Ross G. Hicks, Joseph E. Mutschelknaus, Bonnie Nannenga-Combs, Matthew S. Bodenstein, Christian A. Camarce, Kyle E. Conklin, Nicholas J. Nowak, Chandrika Vira, John Christopher Rozendaal and Michael E. Joffre
CORRESPONDENCE INFORMATION
NAME Tracy-Gene G. Durkin
FIRM NAME Sterne, Kessler, Goldstein & Fox P.L.L.C.
STREET 1100 New York Avenue, NW
CITY Washington
STATE District of Columbia
COUNTRY United States
ZIP/POSTAL CODE 20005
PHONE 202-371-2600
FAX 202-371-2540
*EMAIL ADDRESS tm@skgf.com; tdurkin@skgf.com; jshirk@skgf.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS RF
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEE DUE 275
*TOTAL FEE PAID 275
SIGNATURE INFORMATION
SIGNATURE /Tracy Durkin/
SIGNATORY'S NAME Tracy-Gene G. Durkin
SIGNATORY'S POSITION Attorney of Record, Washington, DC Bar Member
SIGNATORY'S PHONE NUMBER 202-371-2600
DATE SIGNED 11/15/2017



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2018)


Trademark/Service Mark Application, Principal Register

Serial Number: 87686582
Filing Date: 11/15/2017

To the Commissioner for Trademarks:

MARK: SYNTHEA (Standard Characters, see mark)
The literal element of the mark consists of SYNTHEA.
The mark consists of standard characters, without claim to any particular font style, size, or color.

The applicant, The MITRE Corporation, a corporation of Delaware, having an address of
      7515 Colshire Drive
      McLean, Virginia 22102-7508
      United States
      202-371-2600(phone)
      202-371-2540(fax)

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class _______: An approach, method, and software program for generating synthetic patients and synthetic electronic patient healthcare records for use by the healthcare industry, for research and innovation purposes, and for educational purposes; software that simulates the lifespan of synthetic patients for use by the healthcare industry, for research and innovation purposes, and for educational purposes; software for modeling primary healthcare encounters, chronic conditions, and treatment protocols within a synthetic patient population for use by the healthcare industry, for research and innovation purposes, and for educational purposes; software for generating synthetic patients; software for simulating patients; software for simulating patients with models of disease progression and corresponding standards of care to produce risk-free, realistic, synthetic, healthcare records at scale; a synthetic patient population simulator used to generate synthetic patients and synthetic patient data; providing synthetic patient data and associated healthcare records; software for generating synthetic patient data; software for generating synthetic patient healthcare records
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.


The applicant's current Attorney Information:
      Tracy-Gene G. Durkin and Robert G. Sterne, Jorge A. Goldstein, David K. S. Cornwell, Robert W. Esmond, Michele A. Cimbala, Michael B. Ray, Robert E. Sokohl, Eric K. Steffe, Michael Q. Lee, John M. Covert, Robert C. Millonig, Donald J. Featherstone, Timothy J. Shea, Jr., Jeffrey T. Helvey, Eldora L. Ellison, Donald R. Banowit, Peter A. Jackman, Michael D. Specht, Gaby L. Longsworth, Lori A. Gordon, Jon E. Wright, Tracy-Gene G. Durkin, Monica Riva Talley, Michelle K. Holoubek, Paul A. Calvo, Marsha A. Rose, Mark W. Rygiel, Byron L. Pickard, Daniel E. Yonan, Jason D. Eisenberg, Kenley K. Hoover, Deborah Sterling, Salvador M. Bezos, Carla Ji-Eun Kim, Paul A. Ainsworth, Jeremiah B. Frueauf, Richard D. Coller, III, Dennies Varughese, Jonathan Tuminaro, Nirav N. Desai, Uma N. Everett, Ross G. Hicks, Joseph E. Mutschelknaus, Bonnie Nannenga-Combs, Matthew S. Bodenstein, Christian A. Camarce, Kyle E. Conklin, Nicholas J. Nowak, Chandrika Vira, John Christopher Rozendaal and Michael E. Joffre of Sterne, Kessler, Goldstein & Fox P.L.L.C.      1100 New York Avenue, NW
      Washington, District of Columbia 20005
      United States
      202-371-2600(phone)
      202-371-2540(fax)
      tm@skgf.com (authorized)
The attorney docket/reference number is 2272.2290000.
The applicant's current Correspondence Information:
      Tracy-Gene G. Durkin
      Sterne, Kessler, Goldstein & Fox P.L.L.C.
      1100 New York Avenue, NW
      Washington, District of Columbia 20005
      202-371-2600(phone)
      202-371-2540(fax)
      tm@skgf.com;tdurkin@skgf.com; jshirk@skgf.com (authorized)
E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Tracy Durkin/   Date: 11/15/2017
Signatory's Name: Tracy-Gene G. Durkin
Signatory's Position: Attorney of Record, Washington, DC Bar Member
Payment Sale Number: 87686582
Payment Accounting Date: 11/16/2017

Serial Number: 87686582
Internet Transmission Date: Wed Nov 15 20:14:50 EST 2017
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XXX-20171115201450
800632-87686582-51081263050b498a029375ab
5edc6d10f754672e4ac23e6eb0ca1d9e663121a8
-CC-6313-20171115142050201150

TEAS RF New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed